Avoiding mistaken epilepsy diagnosis in newborns.
Helen Adams1, Karen Greaves2, Siba Prosad Paul2
1University of Bristol.
Summary
Benign neonatal sleep myoclonus (BNSM) is a common, harmless condition in newborns. Healthcare providers recognizing BNSM can prevent misdiagnosis as epilepsy, reassuring parents.
Area of Science:
- Neonatal neurology
- Pediatric sleep disorders
- Clinical neurology
Background:
- Benign neonatal sleep myoclonus (BNSM) is a common condition presenting with involuntary muscle jerks during sleep in newborns.
- It is frequently misdiagnosed as infantile epilepsy due to similar clinical manifestations, leading to unnecessary investigations and parental anxiety.
- Accurate differentiation between BNSM and epilepsy is crucial for appropriate clinical management.
Purpose of the Study:
- To increase awareness among healthcare professionals regarding the characteristics of benign neonatal sleep myoclonus.
- To provide clear diagnostic criteria to differentiate BNSM from neonatal seizures.
- To reduce the misdiagnosis rate of BNSM as epilepsy in the neonatal population.
Main Methods:
- Review of clinical features, electroencephalographic (EEG) findings, and response to stimuli in infants diagnosed with BNSM.
- Comparison of BNSM characteristics with established criteria for neonatal seizures.
- Analysis of case reports and literature on differential diagnosis between BNSM and epilepsy.
Main Results:
- Benign neonatal sleep myoclonus typically presents with brief, bilateral, and synchronous myoclonic jerks involving the limbs and trunk during non-rapid eye movement (NREM) sleep.
- EEG recordings in infants with BNSM are usually normal and do not show epileptiform discharges.
- Myoclonic movements in BNSM can often be suppressed by gentle physical stimuli, unlike epileptic seizures.
Conclusions:
- Healthcare professionals should be aware of benign neonatal sleep myoclonus as a distinct, non-pathological entity.
- Recognizing the specific clinical and EEG features of BNSM can prevent its misdiagnosis as epilepsy.
- Proper identification of BNSM ensures appropriate reassurance for parents and avoids unnecessary anti-epileptic drug treatment.
Related Concept Videos
Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification
2.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Inborn Errors of Metabolism
985
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
985


